Advik Laboratories Ltd — Important, 03-03-2026: Company Update

MPS Pharmaa's Board has approved the permanent retrenchment of 10 factory workers. This decision aligns with the company's strategic diversification into manufacturing Ayurvedic, Unani, Homeopathic medicines, and Nutraceutical products. The new business operations demand a specialized workforce, prompting this operational realignment and workforce rationalization. This move is expected to optimize employee costs, with all statutory dues and compensation being settled for affected workers, reflecting a pivot towards new healthcare solutions and market trends.